Citation Impact
Citing Papers
2016 ESC Position Paper on cancer treatments and cardiovascular toxicity developed under the auspices of the ESC Committee for Practice Guidelines
2016 Standout
Diagnosis and management of acute myeloid leukemia in adults: recommendations from an international expert panel, on behalf of the European LeukemiaNet
2009 Standout
Empiric Combination Antibiotic Therapy Is Associated with Improved Outcome against Sepsis Due to Gram-Negative Bacteria: a Retrospective Analysis
2010
Management of Adults With Hospital-acquired and Ventilator-associated Pneumonia: 2016 Clinical Practice Guidelines by the Infectious Diseases Society of America and the American Thoracic Society
2016 Standout
PARP inhibitors: Synthetic lethality in the clinic
2017 StandoutScience
Newly diagnosed and relapsed follicular lymphoma: ESMO Clinical Practice Guidelines for diagnosis, treatment and follow-up
2011
Delivering safer immunotherapies for cancer
2017
Severe interstitial lung disease in connective tissue disease: rituximab as rescue therapy
2012
Hypersensitivity from Intravenous Iron Products
2014
Impact of Treatment Strategy on Outcomes in Patients with Candidemia and Other Forms of Invasive Candidiasis: A Patient-Level Quantitative Review of Randomized Trials
2012 Standout
IDH1andIDH2Mutations in Gliomas
2009 Standout
Inflammation and Cancer: Triggers, Mechanisms, and Consequences
2019 Standout
2011 ACCF/AHA/SCAI Guideline for Percutaneous Coronary Intervention
2011 Standout
Guidelines for Preventing Infectious Complications among Hematopoietic Cell Transplantation Recipients: A Global Perspective
2009 Standout
Ovarian cancer
2014 Standout
Risk Assessment and Treatment of Low-Risk Patients with Febrile Neutropenia
2006
Acute Infective Endocarditis
2009
Central venous access in oncology: ESMO Clinical Practice Guidelines
2015
Outcomes of early switching from intravenous to oral antibiotics on medical wards
2009
Lung infections after cancer chemotherapy
2008
Systemic sclerosis
2017 Standout
Bendamustine plus rituximab versus CHOP plus rituximab as first-line treatment for patients with indolent and mantle-cell lymphomas: an open-label, multicentre, randomised, phase 3 non-inferiority trial
2013 Standout
Fluoroquinolones or macrolides alone versus combined with β-lactams for adults with community-acquired pneumonia: Systematic review and meta-analysis
2015
Systematic review and meta-analysis of the discriminatory performance of risk prediction rules in febrile neutropaenic episodes in children and young people
2010
Severe Sepsis and Septic Shock
2013 Standout
A survival benefit of combination antibiotic therapy for serious infections associated with sepsis and septic shock is contingent only on the risk of death: A meta-analytic/meta-regression study
2010
Delivery technologies for cancer immunotherapy
2019 Standout
Antibody therapy of cancer
2012 Standout
Exploring in vitro expression and immune potency in mice using mRNA encoding the Plasmodium falciparum malaria antigen, CelTOS
2022 StandoutNobel
Primary breast cancer: ESMO Clinical Practice Guidelines for diagnosis, treatment and follow-up
2010 Standout
Combination cediranib and olaparib versus olaparib alone for women with recurrent platinum-sensitive ovarian cancer: a randomised phase 2 study
2014
Meta-analysis of Randomized Controlled Trials of Vancomycin for the Treatment of Patients With Gram-Positive Infections: Focus on the Study Design
2012
Targeting macrophages: therapeutic approaches in cancer
2018
The efficacy of non-carbapenem antibiotics for the treatment of community-onset acute pyelonephritis due to extended-spectrum -lactamase-producing Escherichia coli
2014
Initial Assessment, Surveillance, and Management of Blood Pressure in Patients Receiving Vascular Endothelial Growth Factor Signaling Pathway Inhibitors
2010
Cardiovascular toxicity of molecularly targeted agents
2009
BTS guidelines for the management of community acquired pneumonia in adults: update 2009
2009
CSF-1R inhibition alters macrophage polarization and blocks glioma progression
2013 Standout
Malignant Gliomas in Adults
2008 Standout
Hindlimb Suspension and SPE-Like Radiation Impairs Clearance of Bacterial Infections
2014 StandoutNobel
GRADE guidelines 6. Rating the quality of evidence—imprecision
2011 Standout
A review of the biomaterials technologies for infection-resistant surfaces
2013 Standout
Comparison between 5-day decitabine and 7-day azacitidine for lower-risk myelodysplastic syndromes with poor prognostic features: a retrospective multicentre cohort study
2020
Rheumatoid arthritis
2010 Standout
The intestinal microbiota and susceptibility to infection in immunocompromised patients
2013
A Randomized, Open-Label, Multicenter Comparative Study of the Efficacy and Safety of Piperacillin-Tazobactam and Cefepime for the Empirical Treatment of Febrile Neutropenic Episodes in Patients with Hematologic Malignancies
2006
Early breast cancer: ESMO Clinical Practice Guidelines for diagnosis, treatment and follow-up
2019 Standout
Rituximab versus Cyclophosphamide in ANCA-Associated Renal Vasculitis
2010 Standout
Recent progress in the diagnosis and treatment of ovarian cancer
2011
BSR and BHPR guidelines for the management of adults with ANCA associated vasculitis
2007
Physico-chemical properties of the new generation IV iron preparations ferumoxytol, iron isomaltoside 1000 and ferric carboxymaltose
2015
Newly diagnosed and relapsed mantle cell lymphoma: ESMO Clinical Practice Guidelines for diagnosis, treatment and follow-up
2017
Compliance with a critical pathway for the management of febrile neutropenia and impact on clinical outcomes
2007
Emergence of MRSA in positive blood cultures from patients with febrile neutropenia—a cause for concern
2008
Idiopathic Inflammatory Myopathies: Current Trends in Pathogenesis, Clinical Features, and Up-to-Date Treatment Recommendations
2012
Chimeric antigen receptor T-cell therapies for lymphoma
2017
Fever of Unknown Origin in Febrile Leukopenia
2007
Treatment and Clinical Outcomes of Urinary Tract Infections Caused by KPC-Producing Enterobacteriaceae in a Retrospective Cohort
2012
Diagnosis and Treatment of Adults with Community-acquired Pneumonia. An Official Clinical Practice Guideline of the American Thoracic Society and Infectious Diseases Society of America
2019 Standout
Staphylococcus aureus Infections: Epidemiology, Pathophysiology, Clinical Manifestations, and Management
2015 Standout
Practice Guidelines for the Diagnosis and Management of Skin and Soft Tissue Infections: 2014 Update by the Infectious Diseases Society of America
2014 Standout
Treatment of invasive candidiasis in neutropenic patients: systematic review of randomized controlled treatment trials
2012
Inflammatory Muscle Diseases
2015 Standout
Transparent Reporting of a multivariable prediction model for Individual Prognosis Or Diagnosis (TRIPOD): Explanation and Elaboration
2015 Standout
Cediranib, an Oral Inhibitor of Vascular Endothelial Growth Factor Receptor Kinases, Is an Active Drug in Recurrent Epithelial Ovarian, Fallopian Tube, and Peritoneal Cancer
2009
Practice Guidelines for the Diagnosis and Management of Skin and Soft-Tissue Infections
2005
G-CSF and GM-CSF in Neutropenia
2015
Antibiotics for community-acquired pneumonia in adult outpatients
2014
Prevention and Treatment of Cancer-Related Infections
2012
Antibiotic Therapy for Adults Hospitalized With Community-Acquired Pneumonia
2016
Clinical Practice Guideline for the Use of Antimicrobial Agents in Neutropenic Patients with Cancer: 2010 Update by the Infectious Diseases Society of America
2011 Standout
Clinical Practice Guidelines by the Infectious Diseases Society of America for the Treatment of Methicillin-Resistant Staphylococcus aureus Infections in Adults and Children
2011 Standout
Next Generation of Fluorine-Containing Pharmaceuticals, Compounds Currently in Phase II–III Clinical Trials of Major Pharmaceutical Companies: New Structural Trends and Therapeutic Areas
2016 Standout
Antimicrobial Resistance in Neisseria gonorrhoeae in the 21st Century: Past, Evolution, and Future
2014 Standout
Klebsiella pneumoniae: Going on the Offense with a Strong Defense
2016 Standout
Update on the diagnosis and treatment of Pneumocystis pneumonia
2010
Impact of a Renal Drug Dosing Service on Dose Adjustment in Hospitalized Patients with Chronic Kidney Disease
2009
Procalcitonin as a Marker of Etiology in Adults Hospitalized With Community-Acquired Pneumonia
2017
Printed educational materials: effects on professional practice and healthcare outcomes
2012 Standout
Invasive Candidiasis
2015 Standout
Practice Guidelines for the Diagnosis and Management of Aspergillosis: 2016 Update by the Infectious Diseases Society of America
2016 Standout
Single-nanometer iron oxide nanoparticles as tissue-permeable MRI contrast agents
2021 StandoutNobel
Clinical Practice Guideline for the Management of Candidiasis: 2016 Update by the Infectious Diseases Society of America
2015 Standout
Chimeric Antigen Receptor Therapy
2018 Standout
Moving towards best practice when using inverse probability of treatment weighting (IPTW) using the propensity score to estimate causal treatment effects in observational studies
2015 Standout
Antimicrobial Prophylaxis and Outpatient Management of Fever and Neutropenia in Adults Treated for Malignancy: American Society of Clinical Oncology Clinical Practice Guideline
2013
Iron-Deficiency Anemia
2015 Standout
β-Lactam Monotherapy vs β-Lactam–Macrolide Combination Treatment in Moderately Severe Community-Acquired Pneumonia
2014
Stenotrophomonas maltophilia: an Emerging Global Opportunistic Pathogen
2012 Standout
2015 ESC Guidelines for the management of infective endocarditis
2015 Standout
2013 IDSA Clinical Practice Guideline for Vaccination of the Immunocompromised Host
2013 Standout
Exame do escarro no manejo clínico dos pacientes com pneumonia adquirida na comunidade
2008
Colonization by Pneumocystis jirovecii and Its Role in Disease
2012
Meta-Analysis: Antibiotic Prophylaxis Reduces Mortality in Neutropenic Patients
2005
2011 ACCF/AHA/SCAI Guideline for Percutaneous Coronary Intervention
2011 Standout
Cyclooxygenase-2 selective non-steroidal anti-inflammatory drugs (etodolac, meloxicam, celecoxib, rofecoxib, etoricoxib, valdecoxib and lumiracoxib) for osteoarthritis and rheumatoid arthritis: a systematic review and economic evaluation
2008
Updated Response Assessment Criteria for High-Grade Gliomas: Response Assessment in Neuro-Oncology Working Group
2010 Standout
Hidden Killers: Human Fungal Infections
2012 Standout
Combination Therapy for Treatment of Infections with Gram-Negative Bacteria
2012
Influence of Multidrug Resistance and Appropriate Empirical Therapy on the 30-Day Mortality Rate of Pseudomonas aeruginosa Bacteremia
2012
Works of Liat Vidal being referenced
Rituximab Maintenance for the Treatment of Patients With Follicular Lymphoma: Systematic Review and Meta-analysis of Randomized Trials
2009
Secondary malignancies following high dose therapy and autologous hematopoietic cell transplantation-systematic review and meta-analysis
2015
Additional anti-Gram-positive antibiotic treatment for febrile neutropenic cancer patients
2005
Prophylaxis of Pneumocystis Pneumonia in Immunocompromised Non-HIV-Infected Patients: Systematic Review and Meta-analysis of Randomized Controlled Trials
2007
Meloxicam in acute episodes of soft-tissue rheumatism of the shoulder
2001
5-azacitidine prolongs overall survival in patients with myelodysplastic syndrome - a systematic review and meta-analysis
2009
Prophylaxis for Pneumocystis pneumonia (PCP) in non-HIV immunocompromised patients
2007
Aminoglycoside drugs in clinical practice: an evidence-based approach
2008
Systematic comparison of four sources of drug information regarding adjustment of dose for renal function
2005
Treatment of Invasive Candidal Infections: Systematic Review and Meta-analysis
2008
Bisphosphonates in the Adjuvant Setting of Breast Cancer Therapy—Effect on Survival: A Systematic Review and Meta-Analysis
2013
Oral versus intravenous antibiotic treatment for febrile neutropenia in cancer patients
2004
Efficacy and safety of aminoglycoside monotherapy: systematic review and meta-analysis of randomized controlled trials
2007
Empirical antibiotics against Gram-positive infections for febrile neutropenia: systematic review and meta-analysis of randomized controlled trials
2005
Intravenous iron supplementation for the treatment of chemotherapy-induced anaemia – systematic review and meta-analysis of randomised controlled trials
2012
Empiric antibiotic coverage of atypical pathogens for community-acquired pneumonia in hospitalized adults
2012
Subcutaneous versus intravenous granulocyte colony stimulating factor for the treatment of neutropenia in hospitalized hemato‐oncological patients: Randomized controlled trial
2013
Rituximab as maintenance therapy for patients with follicular lymphoma
2009
Prophylaxis for Pneumocystis pneumonia (PCP) in non-HIV immunocompromised patients
2014
Antibiotic prophylaxis for bacterial infections in afebrile neutropenic patients following chemotherapy
2012
Oral versus intravenous antibiotic treatment for febrile neutropenia in cancer patients
2013
A phase II study of cediranib (AZD2171) in recurrent or persistent ovarian, peritoneal or fallopian tube cancer: Final results of a PMH, Chicago and California consortia trial
2008
Maintenance Therapy for Patients with Mantle Cell Lymphoma (MCL) - a Systematic Review and Meta-Analysis of Randomized Controlled Trials (RCTs)
2016